Rinvoq Vs Olumiant

Adults with severe alopecia areata can use the prescription drug olumiant, a Janus kinase (JAK) inhibitor.

Adults with moderately to severely active rheumatoid arthritis who have tried therapy with one or more tumour necrosis factor (TNF) blockers but found that it was either intolerable or did not work well enough.

On the other hand, RINVOQ, on the other hand, is a JAK inhibitor that acts within your cells to disrupt certain signals considered to be the source of inflammation.

RINVOQ, a once-daily medication, has been demonstrated in clinical tests to help manage symptoms in 6 illnesses.

Adults with moderate to severe rheumatoid arthritis (RA) who have tried one or more tumour necrosis factor (TNF) blocker medications but found that they did not work or could not be tolerated might take RINVOQ, a prescription medication.

Adults with active psoriatic arthritis (PsA) who have tried one or more TNF blockers but found that they either did not function as well as expected or were intolerable.